BRIEF published on 07/15/2024 at 15:38, 4 months 9 days ago The Vanguard Group Discloses Position in Network International Holdings plc Securities Takeover Code Vanguard Group Network International
BRIEF published on 07/15/2024 at 15:37, 4 months 9 days ago The Vanguard Group, Inc. Discloses Position in Tritax EuroBox Securities Form 8.3 Position Disclosure Vanguard Tritax EuroBox
BRIEF published on 07/15/2024 at 15:36, 4 months 9 days ago The Vanguard Group Discloses Position in Redrow plc Form 8.3 Disclosure Redrow Plc Vanguard Stock Acquisition
PRESS RELEASE published on 07/15/2024 at 15:36, 4 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporation The Vanguard Group, Inc. discloses a 11.16% ownership in Quanex Building Products Corp. as of 12 July 2024 The Vanguard Group, Inc. Form 8.3 Ownership Disclosure Financial Disclosure Quanex Building Products Corporation
PRESS RELEASE published on 07/15/2024 at 15:35, 4 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company The Vanguard Group, Inc. discloses a 11.72% stake in International Paper Company. Public disclosure under Rule 8.3 of the Takeover Code Rule 8.3 Takeover Code The Vanguard Group Inc. Stake Disclosure International Paper Company
BRIEF published on 07/15/2024 at 15:35, 4 months 9 days ago The Vanguard Group Discloses Stake in Virgin Money UK plc The Vanguard Group Takeover Code Securities Disclosure Stock Acquisition Virgin Money UK
PRESS RELEASE published on 07/15/2024 at 15:34, 4 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: Hipgnosis Songs Fund Limited The Vanguard Group, Inc. discloses a 1.33% stake in Hipgnosis Songs Fund Limited in a Form 8.3 filing under the Takeover Code Form 8.3 Vanguard Group Inc. Takeover Code Stake Disclosure Hipgnosis Songs Fund Limited
BRIEF published on 07/15/2024 at 15:34, 4 months 9 days ago The Vanguard Group, Inc. Announces Interest in Crest Nicholson Holdings plc Takeover Code Vanguard Group Financial Disclosure Shareholding Crest Nicholson Holdings
PRESS RELEASE published on 07/15/2024 at 15:34, 4 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: Balanced Commercial Property Trust Limited The Vanguard Group, Inc. discloses a 4.31% interest in Balanced Commercial Property Trust Limited's securities as of 15 July 2024 Securities Disclosure The Vanguard Group Interests Balanced Commercial Property Trust Limited
BRIEF published on 07/15/2024 at 15:33, 4 months 9 days ago The Vanguard Group, Inc. Discloses Position in Wood Group (John) plc Form 8.3 Disclosure The Vanguard Group Takeover Code Wood Group
Published on 11/25/2024 at 04:00, 40 minutes ago Tanzania Safaris Unveils New Luxury Adventure Packages for 2025
Published on 11/22/2024 at 23:55, 2 days 4 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 2 days 5 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 2 days 5 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/24/2024 at 19:16, 9 hours 24 minutes ago EQS-Adhoc: RENK Group AG: Termination of mandate of CEO Susanne Wiegand and appointment of Dr. Alexander Sagel as CEO
Published on 11/24/2024 at 19:07, 9 hours 32 minutes ago EQS-Adhoc: ABO Energy KGaA reduces forecast for the 2024 annual result to EUR 20 to 25 million and confirms market expectation for the 2025 financial year
Published on 11/22/2024 at 18:14, 2 days 10 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 2 days 10 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 06:58, 3 days 21 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 4 days 9 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 4 days 10 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 4 days 10 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
